Press coverage, certifications, recognitions and company milestones — from the Piramal Alternatives investment to new accreditations and global partnerships.
Expert perspectives on nasal spray drug delivery, injectable manufacturing, nutraceutical formulation, regulatory affairs and global export markets — alongside the latest Biodeal company news.
Looking for a reliable third-party injection manufacturer in India? Learn how Biodeal Pharmaceuticals supports pharma brands with WHO-GMP certified manufacturing, quality-focused processes, scalable production, and dependable injectable solutions.
Biodeal Pharmaceuticals successfully concludes its ₹110 crore investment partnership with Piramal Alternatives, delivering over 20% IRR and strong business growth
Explore how Biodeal Pharmaceuticals is supporting the growing nasal drug delivery market in India with advanced nasal spray manufacturing, analytical expertise, scalable production, and end-to-end CDMO solutions for pharmaceutical companies.
A practical comparison of the two dominant nasal-spray formats, and how to choose the right one for your molecule.
Inside the Grade A/B clean rooms, aseptic filling and controls behind reliable sterile injectable production.
Why freeze-drying matters for stability, and what it means for your injectable development timeline.
The credentials, capabilities and quality systems that separate a reliable CDMO partner from the rest.
How our formulation, device and dossier teams take a molecule from concept to regulated-market launch.
A key regulated-market clearance that extends Biodeal's reach into North America and validates our quality systems.
For press enquiries, interviews, company facts or media assets, reach our communications team — we typically respond within 48 business hours.